| Website | dupontcapital.com |
| Phone | 302.477.6000 |
| Employees | |
| Founded | 1977 |
DuPont Capital Management (DCM) offers prudent, proven investment management services and global perspective to institutional investors. As an asset manager affiliated with a plan sponsor, they possess a unique understanding of the challenges facing plan sponsors and how they expect those challenges to be met. From knowing the importance of consistent better-than-market performance to making skilled use of asset allocation strategies and more, they approach their work through the eyes of the manager and those of the client.
They apply value-based global investment capabilities that combine valuation and risk control disciplines, within and across asset classes and international boundaries, to produce risk-efficient excess returns that satisfy their clients’ investment objectives
| Company | Date | Round | Size | Participants |
| Noble Biomaterials | 2/12 | Series B | $8M | 3 |
| Actelis Networks | 9/09 | Venture Round | $10M | 10 |
| Stream5 | 9/09 | Venture Round | 2 | |
| Actelis Networks | 4/09 | Venture Round | $4.7M | 4 |
| Altierre | 5/08 | Series C | $8M | 6 |
| Actelis Networks | 4/08 | Series F | $15M | 4 |
| Altierre | 4/07 | Series B | $17M | 5 |
| Actelis Networks | 1/07 | Series E | $22M | 10 |
| NeoPhotonics | 6/06 | Series C | $75M | 10 |
